Chaft, J. E., Tsuboi, M., Weder, W. (2026). Reply to: “NeoADAURA: Can We Afford to Overlook Objective Response Rates?” and “Is Major Pathologic Response the Best Surrogate End Point for Neoadjuvant Trials?”. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-02551